Acura Pharmaceuticals (NASDAQ: ACUR) posted its quarterly earnings results on Monday. The company reported ($0.86) earnings per share (EPS) for the quarter.

Shares of Acura Pharmaceuticals (ACUR) traded up 0.49% during mid-day trading on Monday, hitting $2.05. Acura Pharmaceuticals (ACUR) has a one year low of $1.06 and a one year high of $4.50. The stock’s 50-day moving average is currently $2.08. The company’s market cap is $94.0 million.

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development and commercialization of products focused on addressing medication abuse and misuse, utilizing its Aversion and Impede Technologies.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.